Carotid endarterectomy versus stenting: an international perspective.
نویسندگان
چکیده
International Perspective To the Editor: With interest we read the comment of Hobson et al entitled “Carotid Artery Stenting and the Recruitment Challenges in a clinical trial.”1 Although we completely share the concerns of the authors regarding slow recruitment into the CREST Trial, constantly growing use of carotid stenting in symptomatic patients outside of protocols, and the lack of evidence in this area, we cannot agree with the perception that it is mostly up to CREST to solve the problems. The authors mention shortly that larger clinical trials “are currently underway in North America and Europe.” With reference 10 they cite the CAVATAS trial that finished recruitment long ago. They state that “recruitment into these trials will also be slow and the data may not be available for the next 2 to 3 years.” As the principal investigators of 3 European Trials, we would like to update the organizers of CREST and the readers of Stroke in the field of what’s going on in the randomized symptomatic carotid endarterectomy versus stenting trials outside of North America. The early results of CAVATAS were published 3 years ago and the results of long-term follow-up were presented at this year’s European Stroke Conference and will be submitted for publication soon. The next on-going trial is the International Carotid Stenting Study (ICSS), the follow-up to the CAVATAS trial. This trial includes North American centers in Canada as well as several European countries and Australia, and its study protocol has been recently published.2 Almost 600 patients are already included in this trial. The second trial, which is also not cited in this article, is the French EVA 3S Trial. Its trial design and protocol amendment has also recently been published.3,4 Almost 500 patients are already included in this trial. The third one is the SPACE Trial. The trial protocol of SPACE has also been published.5,6 It is not adequately referenced by mentioning a poster at the ASA Meeting 2 years ago. This trial is probably the most advanced trial, and termination of recruitment is expected in the next couple of months. Therefore, it will not take 3 years until data from this German-Austrian Trial are available. By the way, it should be mentioned that the 3 European Trials have already agreed to perform a joint data analysis after completion and publication of all 3 trials.7 We hope we will also be able to include results from CREST in this meta-analysis. We wish our American colleagues a lot of success in improving the recruitment rates. We need much more data from all the trials before it will be clear which treatment is optimal for symptomatic carotid stenosis.
منابع مشابه
Cost-utility analysis of stenting versus endarterectomy in the International Carotid Stenting Study.
BACKGROUND The International Carotid Stenting Study was a multicenter randomized trial in which patients with symptomatic carotid artery stenosis were randomly allocated to treatment by carotid stenting or endarterectomy. Economic evidence comparing these treatments is limited and inconsistent. AIMS We compared the cost-effectiveness of stenting versus endarterectomy using International Carot...
متن کاملLow Complication Rates for Carotid Artery Stenting in the Credentialing Phase of the Carotid Revascularization Endarterectomy Versus Stenting Trial
International Stroke Conference Oral Presentations
متن کاملANGIOPLASTY AND STENTING OF CAROTID ARTERY STENOSIS WITH EMBOLIC PROTECTION DEVICES
Background: Carotid artery stenting (CAS) has recently been recommended as an alternative to carotid endarterectomy (CEA) by some clinicians. Objective: This study was designed to evaluate the success rate and in-hospital and 30-day adverse events in our first experiences in Iran for CAS with protection devices, to document our results and guide further use of CAS. Methods: From December 2...
متن کاملDesign of the Carotid Revascularization Endarterectomy vs. Stenting Trial (CREST).
RATIONALE Carotid endarterectomy (CEA) and medical therapy were shown superior to medical therapy alone for symptomatic (> or =50%) and asymptomatic (> or =60%) stenosis. Carotid angioplasty stenting (CAS) offers a less invasive alternative. Establishing safety, efficacy, and durability of CAS requires rigorous comparison with CEA in symptomatic and asymptomatic patients. AIMS The objective i...
متن کاملEffect of white-matter lesions on the risk of periprocedural stroke after carotid artery stenting versus endarterectomy in the International Carotid Stenting Study (ICSS): a prespecified analysis of data from a randomised trial
BACKGROUND Findings from randomised trials have shown a higher early risk of stroke after carotid artery stenting than after carotid endarterectomy. We assessed whether white-matter lesions affect the perioperative risk of stroke in patients treated with carotid artery stenting versus carotid endarterectomy. METHODS Patients with symptomatic carotid artery stenosis included in the Internation...
متن کاملCarotid stenting: is there an operator effect? A pooled analysis from the carotid stenting trialists' collaboration.
BACKGROUND AND PURPOSE Randomized clinical trials show higher 30-day risk of stroke or death after carotid artery stenting compared with surgery. We examined whether operator experience is associated with 30-day risk of stroke or death in the Carotid Stenting Trialists' Collaboration database. METHODS The Carotid Stenting Trialists' Collaboration is a pooled individual patient database includ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید
ثبت ناماگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید
ورودعنوان ژورنال:
- Stroke
دوره 37 2 شماره
صفحات -
تاریخ انتشار 2006